Search

everythinglearnresearchcommunity

for

Search:↓

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Baricitinib is effective as a treatment for severe hair loss.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib is effective and safe for treating severe alopecia areata.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

A woman developed folliculitis after taking acitretin for psoriasis, which was treated with skin dressing and antibiotics.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Topical cyclosporin may help delay hair loss.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Botulinum toxin A injections reduce scalp oil for up to 3 months.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.